Page 184 - Immunization Practices News Today

CECC head says border restrictions will ease when downward COVID trend begins between September early October | 2022-08-26 10:52:00

Moderna Inc. completed its filing to request U.S. clearance for a booster shot that targets the latest omicron COVID variants, a move to provide more protection against the persistent coronavirus.

Moderna has applied for FDA approval for its coronavirus vaccine targeting the BA.4/BA.5 omicron variants.

By Carma Hassan and Brenda Goodman, CNN

A sweeping new law answers some of the AAFP’s high-priority advocacy aims on health care coverage, out-of-pocket costs and more.

The Food and Drug Administration plans to authorize updated versions of Pfizer-BioNTech’s and Moderna’s Covid boosters around Labor Day, said two people familiar with the discussions.

Even as COVID-19 restrictions ease, the pandemic is still far from over for immunocompromised patients, who face enduring and significant risks from the virus. How can we protect the most medically vulnerable members of our community?

Moderna has joined the ranks of vaccine manufacturers who have submitted a bivalent COVID-19 booster to the Food and Drug Administration for emergency use authorization as the Biden administration eyes a fall rollout for the updated shots.

If the FDA authorizes the updated vaccines, they could become available in September.

One in twenty-three people who received the COV vaccine experienced a severe enough adverse reaction to trigger an insurance claim.